Japan's growth rates are expected to be 1.0% for both 2025 and 2026. The Eurozone's economic growth has been slightly revised ...

Nike (NYSE: NKE) is unlikely to experience a strong turnaround in China in the near term, according to UBS analysts, who ...

Following the report, JPMorgan analyst Mark Murphy downgraded OneStream from Overweight to Neutral, and trimmed the price ...

U.S. stock futures slipped marginally lower Wednesday, as investors awaited the release of key inflation data that could ...

The positive trial results have not only demonstrated rosnilimab's potential in treating RA but have also validated AnaptysBio's scientific approach in targeting PD-1 co-inhibitory receptors on ...

For the fiscal year 2024, total revenue climbed by 31% to $489.4 million, and subscription revenue surged by 41% to $428.2 million. However, the GAAP operating loss widened significantly to $319.5 ...

Investing.com -- Needham & Co analysts started research coverage of VF Corporation (NYSE: VFC ), and Ralph Lauren (NYSE: RL) ...

Investing.com -- Shares of Xilio Therapeutics Inc surged 175% on Wednesday in pre-market trading following the announcement ...

(Reuters) -From Google to Target (NYSE: TGT ), many major U.S. companies have dropped or considered altering their diversity, ...

Bernstein analysts have adjusted their outlook on European airline stocks, upgrading Lufthansa while downgrading International Airlines Group (LON:ICAG) (IAG).  The brokerage cited valuation ...

The FDA's green light for GOMEKLI is a significant achievement for SpringWorks, especially as it comes with a rare pediatric disease priority review voucher, which could be valued at around $100 ...

CHICAGO - CME Group (NASDAQ: CME) reported strong fourth-quarter results on Wednesday, beating earnings estimates and posting record full-year revenue as the derivatives marketpla ...